Diego J. Maselli MD, FCCP ATSF (@maselliMD) profile picture

Professor and Chief, Division of Pulmonary Diseases and Critical Care, UT Health at San Antonio

Joined June 2016
Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)Photo by Diego J. Maselli MD, FCCP ATSF (@maselliMD)
Diego J. Maselli MD, FCCP ATSF retweeted
ECCMID 2026 No induction of resistance over 6 months with monoclonal antibody therapy against pseudomonas in bronchiectasis Encouraging beneficial changes to the microbiome too Encouraging early results presented by @beccahull_
2
10
1
41
1,719
Diego J. Maselli MD, FCCP ATSF retweeted
Characterisation of the eosinophilic endotype of bronchiectasis We use a novel method of quantifying eosinophil granule proteins in sputum: Eosinophilic inflammation is present in bronchiectasis but poorly associated with blood eosinophils @EMBARCnetwork thorax.bmj.com/content/early…
19
36
1,985
Diego J. Maselli MD, FCCP ATSF retweeted
Time to get your heart racing (literally)! Deep dive into cardiogenic shock at 945 am 🚑💔 #CHEST2025 #CHESTSoMe @sfaiz212 @KhasterDinh @PatelMaulin17
2
2
316
Diego J. Maselli MD, FCCP ATSF retweeted
Obstructive Lung Disease Academy at #CHEST2025 @AdrishMD @BCMCME @BCMLungInst @BCM_Lung
5
10
39
2,779
Diego J. Maselli MD, FCCP ATSF retweeted
📣 Semana ALAT del Pulmón 2025 🫁 “Desafiando los hechos” 📌 Martes 23/09 – 18:05 h (MX) 👤 Ponente: 🇺🇸 Diego Maselli C. 🎙 Tema: PRO: Reducir la dosis de biológicos 💻 Virtual y sin costo ➡️ bit.ly/42cUuQo #SemanaALATdelPulmón
5
1
7
600
Diego J. Maselli MD, FCCP ATSF retweeted
Can emphysema be repaired? What started as a bold idea from Steve Rennard led to the creation of ASTE (Advanced Study to Treat Emphysema). Our first publication is out, laying the groundwork for the approach we’re taking to tackle this challenge. #cureCOPD 🔗Link here: atsjournals.org/doi/abs/10.1…
4
22
54
3,326
Diego J. Maselli MD, FCCP ATSF retweeted
Look what just appeared online as part of the ERS congress programme for September 👀 Can't wait to share the NEW ERS Bronchiectasis Guidelines 2025! Join us in Amsterdam #bronchiectasis #Guidelines @AlibertiStefano @EMBARCnetwork
3
17
1
76
3,737
Diego J. Maselli MD, FCCP ATSF retweeted
The countdown is on, come join us! bit.ly/3Gi3V9i #PH #ATS2025 @atscommunity @ATS_PC
3
7
305
Diego J. Maselli MD, FCCP ATSF retweeted
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a... sciencedirect.com/science/ar… @BCMCME @BCM_Lung @BCMLungInst
2
9
337
Diego J. Maselli MD, FCCP ATSF retweeted
Just published online at @ERSpublications ERR A deep dive into neutrophils and their role in bronchiectasis An exciting new era with therapies targeting this treatable trait
3
27
1
76
4,663
2 subjects enrolled in 48 hours in the NEUTRALIZE AKI Trail!!! Great collaboration with Nephrology/Critical Care!! @BandakGhassan @UTHSA_PCCM @UTHealthSA 🔥🔥💪💪
1
2
170
Diego J. Maselli MD, FCCP ATSF retweeted
Management of #Asthma and #COPD Exacerbations in Adults in the ICU Read the full research in the March issue of #journal_CHESTCritCare: hubs.la/Q03bNLd00 #JournalCHEST #CritCare #MedEd
61
3
134
12,755
Phenomenal Mecine Grand Rounds at UT Health San Antonio on Bronchiectasis by Dr Ashley Losier!! @AshleyLosierMD @UTHSA_PCCM @UTHealthSA @YaleMed
1
2
10
305
Diego J. Maselli MD, FCCP ATSF retweeted
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores - Respiratory Medicine resmedjournal.com/article/S0…
1
19
46
2,106
Great updates on bronchiectasis from Dr Meilinh Thi!! @UTHSA_PCCM
2
8
470
Fantastic talk by Dr. Estrada!! @REstradaMD Forum on Advances in Pulmonary Care @UTHSA_PCCM
3
3
355
Diego J. Maselli MD, FCCP ATSF retweeted
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials - The Lancet Respiratory Medicine thelancet.com/journals/lanre… @BCMLungInst @BCM_Lung
2
12
28
1,300
Phenomenal talks!! Join us on 3/1/2025. Free registration! @UTHSA_PCCM cmetracker.net/UTHSCSA/Publi…
1
2
80
“The last bronchial thermoplasty” 🪦 The end of an era in severe asthma therapy? @UTHSA_PCCM
3
105